Quote For Amgen Inc. AMGN.O
sector: Healthcare ·
industry: Biotechnology ·
As of
9 Feb 2010
57.21USD
$57.21
9 Feb 2010
-0.44%
$57.21
--
18,732,186
$58.40
$56.70
$64.76
$44.96
0.50
9,141,881
News
Press Releases
Key Developments
Officers
| Name |
Current Position |
Compensation |
| Sharer, Kevin |
Chairman of the Board, President, Chief Executive Officer |
14,512,800 |
| Bradway, Robert |
Chief Financial Officer, Executive Vice President |
4,236,080 |
| Bonanni, Fabrizio |
Executive Vice President - Operations |
6,268,960 |
Key Ratios and Statistics
| Share Related Items |
| Market Cap (Mil.) |
$56,923.95 |
| Shares Outstanding (Mil.) |
995.00 |
| Float (Mil.) |
991.49 |
| |
| Dividend Information |
| Yield % |
-99,999.99 |
| Annual Dividend ($ USD) |
-- |
| Payout Ratio(TTM) % |
-- |
| |
| Financial Strength |
| Quick Ratio |
4.32 |
| Current Ratio |
4.89 |
| LT Debt/Equity |
46.77 |
| Total Debt/Equity |
46.77 |
| |
| Valuation Ratios |
| Price/Earnings(TTM) |
12.69 |
| Price/Sales(TTM) |
3.89 |
| Price/Book(TTM) |
2.51 |
| Price/Cash Flow(TTM) |
10.41 |
| |
|
| Per Share Data |
| Earnings(TTM) |
$4.53 |
| Sales(TTM) |
$14.33 |
| Book Value(MRQ) |
$22.78 |
| Cash Flow(TTM) |
$5.35 |
| Cash(MRQ) |
$13.51 |
|
| Management Effectiveness |
| Return on Equity(TTM) |
21.15 |
| Return on Assets(TTM) |
12.11 |
| Return on Investment(TTM) |
13.69 |
| |
|
| Margins |
| Gross Margin(TTM) % |
85.72 |
| Operating Margin(TTM) % |
37.60 |
| Profit Margin(TTM) % |
31.45 |
|
| |
|
UK
US
- Europe
- Asia
- UK Most Actives